Your browser doesn't support javascript.
loading
Omalizumab as a therapeutic option for nasal polyposis in moderate-to-severe persistent allergic asthma: evidence from a prospective study in a real-world setting
Ruiz-Hornillos, Javier; Rodríguez Jiménez, B; Feliu Vila, A; Moreno Fernández, A; Hernández García, MJ; Domínguez-Ortega, J.
Affiliation
  • Ruiz-Hornillos, Javier; Infanta Elena University Hospital. Allergy Department. Valdemoro. Spain
  • Rodríguez Jiménez, B; University Hospital of Getafe. Allergy Department. Getafe. Spain
  • Feliu Vila, A; Tajo University Hospital. Allergy Department. Aranjuez. Spain
  • Moreno Fernández, A; Virgen de la Luz Hospital. Allergy Department. Cuenca. Spain
  • Hernández García, MJ; Infanta Elena University Hospital. Otorhinolaryngology Department. Valdemoro. Spain
  • Domínguez-Ortega, J; Hospital La Paz Institute for Health Research (IdiPAZ). Allergy Department. Madrid. Spain
J. investig. allergol. clin. immunol ; 30(6): 470-472, 2020. tab
Article in En | IBECS | ID: ibc-202606
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
No disponible
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Asthma / Nasal Polyps / Anti-Asthmatic Agents / Omalizumab Limits: Adult / Female / Humans / Male Language: En Journal: J. investig. allergol. clin. immunol Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Asthma / Nasal Polyps / Anti-Asthmatic Agents / Omalizumab Limits: Adult / Female / Humans / Male Language: En Journal: J. investig. allergol. clin. immunol Year: 2020 Document type: Article